Search

everythinglearnresearchcommunity

for

Search:↓

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Dual anti-seizure medications, especially valproic acid with lamotrigine, often cause more side effects like hair loss and memory issues.

Careful management of blood thinners is crucial for lupus patients with APS.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Analog 23 is a promising compound for prostate cancer treatment.

Inhibiting plant sterols reduces grapevine pathogen reproduction.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Apremilast showed mixed results for treating severe alopecia areata.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.